+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Oxaliplatin"

From
From
Metastatic Colorectal Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Metastatic Colorectal Cancer - Pipeline Insight, 2025

  • Drug Pipelines
  • March 2025
  • 280 Pages
  • Global
From
Colorectal Cancer (CRC) Pipeline Analysis Report - Product Thumbnail Image

Colorectal Cancer (CRC) Pipeline Analysis Report

  • Report
  • August 2024
  • 150 Pages
  • Global
From
From
Colorectal Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Colorectal Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 550 Pages
  • Global
From
From
From
Colon Cancer Treatment Drugs Markets in China - Product Thumbnail Image

Colon Cancer Treatment Drugs Markets in China

  • Report
  • August 2024
  • 199 Pages
  • China
From
From
  • 13 Results (Page 1 of 1)
Loading Indicator

Oxaliplatin is a chemotherapy drug used to treat colon cancer. It is a platinum-based drug, meaning it works by interfering with the growth of cancer cells. Oxaliplatin is often used in combination with other drugs, such as 5-fluorouracil and leucovorin, to create a more effective treatment. It is typically administered intravenously, and is used to treat both early and advanced stages of colon cancer. Oxaliplatin is a relatively new drug, having been approved by the FDA in 2002. It has become a popular treatment option due to its effectiveness and relatively low side effects. Common side effects include nausea, vomiting, and fatigue. The Oxaliplatin market is highly competitive, with many companies offering their own versions of the drug. Some of the major players in the market include Sanofi, Pfizer, Merck, and Bristol-Myers Squibb. Show Less Read more